Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 90 Neoplasms, Plasma Cell 28 Central Nervous System Neoplasms 11 Recurrence 10 Glioblastoma 10 Neoplasms 9 Carcinoma, Hepatocellular 9 Brain Neoplasms 9 Gliosarcoma 8 Melanoma 6 Lung Neoplasms 6 Leukemia 6 Glioma 6 Carcinoma, Non-Small-Cell Lung 6 Waldenstrom Macroglobulinemia 5 Prostatic Neoplasms 5 Lymphoma, Mantle-Cell 5 Myeloproliferative Disorders 4 Lymphoma, B-Cell, Marginal Zone 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Immunoglobulin Light-chain Amyloidosis 4 Colorectal Neoplasms 4 Carcinoma, Renal Cell 4 Astrocytoma 4 Uveal Melanoma 3 Oligodendroglioma 3 Neuroblastoma 3 Myelodysplastic-Myeloproliferative Diseases 3 Myelodysplastic Syndromes 3 Medulloblastoma 3

Interventions

Pregabalin 5 Lidocaine 4 Surveys and Questionnaires 3 Bupivacaine 3 ziconotide 2 Transcranial Magnetic Stimulation 2 Oxycodone 2 Gabapentin 2 Capsaicin 2 Amitriptyline 2 onabotulinum toxin A 1 Yoga 1 Vitamin B 6 1 Vitamin B 12 1 Vinorelbine 1 Vincristine 1 Transcutaneous Electric Nerve Stimulation 1 Thalidomide 1 Telmisartan 1 Tapentadol 1 Spinal Cord Stimulation 1 Sodium Chloride 1 Saline Solution 1 Radiofrequency Ablation 1 Plastic Surgery Procedures 1 Paclitaxel 1 Oxaliplatin 1 Morphine 1 Methadone 1 Manipulation, Osteopathic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neuralgia × Thalidomide × Clear all

NCT00284505 2008-12-05

Use of Thalidomide in Patients With Arachnoiditis

Washington University School of Medicine

Phase 2 Completed

Arachnoiditis, Neuralgia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡